-
Uterine leiomyoma: DNA methylation, chromatin activity and gene expression
Study
EGAS00001004499
-
Ewings_Sarcoma_RNA_seq_drug_sensitivity
Study
EGAS00001000419
-
Whole genome sequencing and whole exome sequencing of mucosal melanoma
Study
EGAS00001000474
-
Transcriptomic analysis of the Phase 3 COMPARZ clinical trial
Study
EGAS00001004534
-
Clinical relevance of somatic copy-number alterations in plasma circulating tumor DNA from advanced EGFR-mutated NSCLC patients treated with osimertinib
Study
EGAS00001004539
-
The genomic landscape of primary cutaneous anaplastic large cell lymphoma (pcALCL)
Study
EGAS00001004429
-
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
Study
EGAS00001004544
-
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients with Advanced Lung Adenocarcinoma
Study
EGAS00001004546
-
A Multifactorial Tumor and Immune Cell Profile Determines Response to Immune Checkpoint blockade in Melanoma
Study
EGAS00001004548
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma
Study
EGAS00001004551
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma - RNA-seq
Study
EGAS00001004552
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma
Study
EGAS00001004564
-
These are from Korean HCC samples with exome sequencing
Study
EGAS00001000604
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM066-WES
Study
EGAS00001004567
-
H014: HES5 mediates NOTCH signaling by interaction with AKT to drive liver carcinogenesis
Study
EGAS00001003329
-
Chromatin immunoprecipitation linked to next-generation whole genome sequencing (ChIP-Seq) for H3K36me3 in paediatric high grade glioma cell lines KKNS4 and SF188 with and without a G34V mutation in H3F3A
Study
EGAS00001001437
-
Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas
Study
EGAS00001000643
-
RRBS MDACC Lung PreCancer
Study
EGAS00001004610
-
Queensland Melanoma Genomic Biomarker Study
Study
EGAS00001004619
-
HumanMethylation450K data from Purified Plasma Cells of Monoclonal gammopathy of unknown significance and Multiple myeloma patients and Healthy donors
Study
EGAS00001000841
-
Mutational Patterns in Metastatic Cutaneous Squamous Cell Carcinoma
Study
EGAS00001003370
-
Targeted sequencing of Burkitt lymphoma tumour samples from the UK's Haematological Malignancy Research Network
Study
EGAS00001004649
-
Anaplastic_Meningioma_WGS_X10
Study
EGAS00001000859
-
Single cell RNA-sequencing of GSCs and GBM tumours
Study
EGAS00001004656
-
Integrated genomic characterization of adrenocortical carcinoma
Study
EGAS00001000665
-
Genomic analysis of patient-derived xenograft models reveals intratumor-heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib
Study
EGAS00001004666
-
WGS of liver cancer in the Japanese population
Study
EGAS00001000678
-
Ultraviolet radiation drives mutations in a subset of mucosal melanomas
Study
EGAS00001004697
-
Molecular profiling of acinar cell carcinoma of the salivary glands
Study
EGAS00001002795
-
Germline and somatic SMARCA4 mutations characterize small-cell carcinoma of the ovary, hypercalcemic type.
Study
EGAS00001000721
-
Spatial transcriptomics analysis of HPV-dependent and HPV-independent vulval squamous cell carcinoma
Study
EGAS00001007981
-
ICGC Oesophageal adenocarcinoma - normal samples
Study
EGAS00001000723
-
Investigate the evolutionary trajectories during invasiveness acquisition in early lung adenocarcinoma
Study
EGAS00001004754
-
Mutational Landscape and Tumor Burden Assessed by Cell-Free DNA in Diffuse Large B-Cell Lymphoma: a Population-based Study
Study
EGAS00001004733
-
Identification of rare germline variants in familial multiple myeloma
Study
EGAS00001004734
-
Integrated genetic and epigenetic analysis defines novel molecular clusters in rhabdomyosarcoma
Study
EGAS00001000884
-
Single cell RNA sequencing of CD19 CAR T-cell infusion products
Study
EGAS00001004576
-
Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation
Study
EGAS00001004763
-
RNASeq of PDX and CDX tumours treated with ADC
Study
EGAS00001004562
-
PSCP_bisulphite_analysis_in_hESCs
Study
EGAS00001001625
-
Genome and transcriptome sequence data from a alveolar rhabdomyosarcoma tumor patient
Dataset
EGAD00001015329
-
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Study
EGAS00001001653
-
Neuroblastoma Cell Line Circle-seq
Study
EGAS00001004796
-
Volasertib preclinical activity in high-risk hepatoblastoma
Study
EGAS00001004827
-
Alveolar Rhabdomyosarcoma case report
Study
EGAS00001004828
-
The Genomic Landscape of Childhood and Adolescent Melanoma
Study
EGAS00001000901
-
Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors
Study
EGAS00001000906
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – Whole exome sequencing
Study
EGAS00001004832
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – RNA sequencing
Study
EGAS00001004833
-
Cross-species genomics identifies TAF12, NFYC and RAD54L as novel choroid plexus carcinoma oncogenes
Study
EGAS00001000961
-
Immune trajectory of response and adverse effect in immunotherapy-treated hepatocellular carcinoma
Study
EGAS00001004843
-
Assessment of cannabidiol and Δ9-tetrahydrocannabiol in mouse models of medulloblastoma
Study
EGAS00001004963
-
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Study
EGAS00001001024
-
Genetic_profiling_of_mucosal_melanoma
Study
EGAS00001001115
-
Predicting brain tumor recurrence: development and validation of a DNA-methylation based nomogram in meningioma
Study
EGAS00001003490
-
High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma
Study
EGAS00001003493
-
Human melanoma samples with and without resistance to BRAF inhibitor therapy
Study
EGAS00001000992
-
ICGC PedBrain DNA methylation sequencing
Study
EGAS00001000561
-
Leeds_Melanoma_Cohort
Study
EGAS00001001158
-
MINCR is a MYC-induced lncRNA able to modulate MYC’s transcriptional network in Burkitt lymphoma cells
Study
EGAS00001001199
-
Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas
Study
EGAS00001004905
-
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Study
EGAS00001001002
-
Spatial heterogeneity in medulloblastoma
Study
EGAS00001001014
-
Mutational Landscape of Plasmablastic Lymphoma
Study
EGAS00001004906
-
ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells-of-origin
Study
EGAS00001004913
-
Exploration of CNV’s and SNV’s in cancers with well-known genetic rearrangements: Identification of additional genetic changes in rearrangements-driven cancer
Study
EGAS00001000673
-
CASCADE metastatic melanoma study
Study
EGAS00001004950
-
Blueprint RNAseq profile of purified plasma cells from multiple myeloma patients and tonsils of healthy donors
Study
EGAS00001001110
-
Analysis of enhancer-promoter connectivity alterations
Study
EGAS00001007411
-
Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.
Study
EGAS00001001179
-
Neuroblastoma relapse trio series from the AMC
Study
EGAS00001001183
-
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
Study
EGAS00001001190
-
Study of non-clear cell renal cell carcinoma
Study
EGAS00001000926
-
Genome-wide DNA-methylation assessment by MethylCap-seq and Infinium HumanMethylation450 BeadChips: an independent large-scale comparison
Study
EGAS00001001191
-
Genome and transcriptome sequence data from a NUT midline carcinoma tumor patient
Dataset
EGAD00001015289
-
Onco-exaptation of an Endogenous Retroviral LTR Drives IRF5 Expression in Hodgkin Lymphoma
Study
EGAS00001001205
-
Clinical outcomes in ctDNA-positive urothelial carcinoma patients treated with adjuvant immunotherapy
Study
EGAS00001004997
-
Comprehensive Transcriptional Analysis of Early Stage Urothelial Carcinoma using whole transcriptome sequencing
Study
EGAS00001001236
-
Paired diagnostic and relapse medulloblastoma sequencing
Study
EGAS00001007120
-
Cell-free DNA TAPS for early cancer detection
Study
EGAS00001004962
-
DNA methylation and somatic mutations converge on cell cycle and define similar evolutionary histories in brain tumors
Study
EGAS00001001255
-
Institut Curie Neuroblastoma Whole Genome Sequencing Diagnosis Relapse
Study
EGAS00001001184
-
Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis
Study
EGAS00001001258
-
Longitudinal Single-Cell Profiling Reveals Molecular Heterogeneity and Tumor-Immune Evolution in Refractory Mantle Cell Lymphoma
Study
EGAS00001005019
-
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma
Study
EGAS00001005023
-
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine
Study
EGAS00001007160
-
Deciphering the mutational landscape and the genome organization of LMS
Study
EGAS00001001262
-
Genomic characterization of esophageal squamous cell carcinoma reveals critical genes underlying tumorigenesis and poor prognosis
Study
EGAS00001001723
-
Growth Hormone (GH) -secreting Pituitary Adenoma
Study
EGAS00001001293
-
Integrated molecular analysis of adult T-cell leukemia/lymphoma
Study
EGAS00001001296
-
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity through a pathogenic lipid metabolism-mTOR circuit
Study
EGAS00001005053
-
Clonal selection and double hit events involving tumor suppressor genes underlie relapse from total therapy
Study
EGAS00001001810
-
Genetic analysis of HLA and immune escape genes in Diffuse Large B-cell Lymphoma
Study
EGAS00001005054
-
Tumor-derived cell lines as pharmacogenomic models to predict therapeutic vulnerabilities in hepatocellular carcinoma
Study
EGAS00001003536
-
Targeting FGFR1 for treatment of soft-tissue sarcoma (H021)
Study
EGAS00001001844
-
Genome and transcriptome sequence data from a angiosarcoma tumor patient
Dataset
EGAD00001015290
-
RNA-sequencing of adult T-cell leukemia/lymphoma samples
Study
EGAS00001003575
-
Cancer-Associated Mutations in Endometriosis without Cancer
Study
EGAS00001003576
-
Multi-omics analysis of primary glioblastoma cell-lines shows recapitulation of pivotal molecular features of parental tumors
Study
EGAS00001001871
-
Mutational analysis of an oligoprogressive sarcomatoid hepatocellular carcinoma treated with an immune checkpoint inhibitor.
Study
EGAS00001005064